CytoSorbents Corporation (CTSO)

[Lakersrback]

Sepsis graveyard indeed...in more ways than one. Time to look at what is working guys. We need to segment the treatment population, use specific treatments on specific patient situations. The expression, "personalized medicine" is very in vogue around the medical circles I travel in. I would point to the upcoming, 150 person, 10 US site, TIGRIS trial for septic shock by EDTXF. It will see PMX used on a 2 to 1 basis over the standard of care and is an OPEN LABEL study that will use existing phase 3 data to help populate the final data points with 28 DAY MORTALITY the primary endpoint. The key is really the diagnostic to accompany the PMX filter that helps form the theragnostic solution. GLTA and let's see a diagnostic screen, guide and confirm the results of Cytosorb....apparently the better mouse trap, but slipping further behind due to a lack of advancement in the scientific arena.